Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Evidence on the Effectiveness and Safety of Spesolimab in the Treatment of Generalized Pustular Psoriasis Flares: A Case Series.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2025
Same author

Arthroscopic fibroarthrolysis and mobilization under anesthesia is a simple, reproducible, and satisfactory method for the treatment of patients with severe post-traumatic arthrofibrosis of the knee.

Revista espanola de cirugia ortopedica y traumatologia·2025
Same author

Megacystis-microcolon-intestinal Hypoperistalsis Syndrome: Four Consecutive Pregnancies with Megacystis.

Journal of medical ultrasound·2024
Same author

Arthroscopic fibroarthrolysis and mobilization under anesthesia is a simple, reproducible, and satisfactory method for the treatment of patients with severe post-traumatic arthrofibrosis of the knee.

Revista espanola de cirugia ortopedica y traumatologia·2024
Same author

[Translated article] The use of arthroscopy does not increase the incidence of complications in the management of Schatzker IV-VI tibial plateau fractures.

Revista espanola de cirugia ortopedica y traumatologia·2023
Same author

The use of arthroscopy does not increase the incidence of complications in the management of Schatzker IV-VI tibial plateau fractures.

Revista espanola de cirugia ortopedica y traumatologia·2023

Related Experiment Video

Updated: Jul 8, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

Cost effectiveness and delivery study for future HIV vaccines.

D C Barth-Jones1, H Cheng, L Y Kang

  • 1Center for Healthcare Effectiveness Research, Wayne State University School of Medicine, Detroit, USA.

AIDS (London, England)
|August 17, 2005
PubMed
Summary

This study surveys policymakers on HIV vaccination strategies to inform cost-effectiveness analyses. Findings will guide sustainable HIV vaccine programs and policy development globally.

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Related Experiment Videos

Last Updated: Jul 8, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Area of Science:

  • Global Health
  • Vaccinology
  • Health Economics

Background:

  • Future HIV vaccination programs require careful planning for effective delivery and financial sustainability.
  • International collaboration is essential for developing and implementing global health strategies.
  • Understanding country-specific challenges is crucial for successful vaccine rollout.

Purpose of the Study:

  • To conduct a policy-maker survey on vaccine delivery and cost-effectiveness for future HIV vaccination programs.
  • To analyze potential HIV vaccination strategies using simulation modeling.
  • To inform decision-makers on policy considerations for country-level HIV vaccine adoption and sustainable programs.

Main Methods:

  • Policy-maker survey across five countries (Brazil, China, Kenya, Peru, Thailand).
  • Data collection on vaccine characteristics and program strategies for cost-effectiveness modeling.
  • Simulation modeling to analyze relative cost-effectiveness of different HIV vaccination strategies.

Main Results:

  • Identified challenges and opportunities for country-level HIV vaccination strategies.
  • Gathered data on vaccine efficacies (susceptibility, infectiousness, disease progression).
  • Provided modeling data to inform vaccination policy considerations.

Conclusions:

  • The study will assist in developing country-level capacities for HIV vaccine policy adoption and delivery.
  • Aims to delineate long-term financial requirements for sustainable HIV vaccination programs.
  • Encourages stakeholder input to advance policy and capacity for future HIV vaccines.